These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 30165040)
1. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET. Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040 [TBL] [Abstract][Full Text] [Related]
2. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways. Wang Z; Zhou H; Yue X; Zhu J; Yang Y; Liu M Anal Bioanal Chem; 2022 Jan; 414(1):497-506. PubMed ID: 34021368 [TBL] [Abstract][Full Text] [Related]
3. Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Wang Z; Shan Y; Wang R; Zhou H; Hu R; Li Y; Zhu J; Yang Y; Liu M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232599 [TBL] [Abstract][Full Text] [Related]
4. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics. Zhang Y; Wavreille AS; Kunys AR; Pei D Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650 [TBL] [Abstract][Full Text] [Related]
5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface. Lubman OY; Waksman G J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339 [TBL] [Abstract][Full Text] [Related]
6. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase. Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716 [TBL] [Abstract][Full Text] [Related]
7. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Eck MJ; Shoelson SE; Harrison SC Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435 [TBL] [Abstract][Full Text] [Related]
8. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101 [TBL] [Abstract][Full Text] [Related]
9. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase. Grucza RA; Bradshaw JM; Mitaxov V; Waksman G Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995 [TBL] [Abstract][Full Text] [Related]
10. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978 [TBL] [Abstract][Full Text] [Related]
11. Mutational investigation of the specificity determining region of the Src SH2 domain. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756 [TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377 [TBL] [Abstract][Full Text] [Related]
13. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling. Muraille E; Bruhns P; Pesesse X; Daëron M; Erneux C Immunol Lett; 2000 Apr; 72(1):7-15. PubMed ID: 10789675 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402 [TBL] [Abstract][Full Text] [Related]
15. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis. Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312 [TBL] [Abstract][Full Text] [Related]
16. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia. Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059 [TBL] [Abstract][Full Text] [Related]
17. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001 [TBL] [Abstract][Full Text] [Related]
18. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701 [TBL] [Abstract][Full Text] [Related]
19. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity. Prasad NK; Werner ME; Decker SJ Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129 [TBL] [Abstract][Full Text] [Related]
20. Expression, purification and characterization of the RhoA-binding domain of human SHIP2 in E.coli. Zhou H; Yue X; Wang Z; Li S; Zhu J; Yang Y; Liu M Protein Expr Purif; 2021 Apr; 180():105821. PubMed ID: 33421554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]